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The CD98 heavy chain (CD98hc) regulates virus-induced cell fusion and monocyte fusion, and is involved
in amino acid transportation. Here, we examined the role that CD98hc plays in the formation of os-
teoclasts using CD98hcﬂox/ﬂoxLysM-cre peritoneal macrophages (CD98hc-defect macrophages). Peritoneal
macrophages were stimulated with co-cultured with osteoblasts in the presence of 1,25(OH)2 vitamin D3,
and thereafter stained with tartrate-resistant acid phosphatase staining solution. The multinucleated
osteoclast formation was severely impaired in the peritoneal macrophages isolated from the
CD98hc-defect mice compared with those from wild-type mice. CD98hc mediates integrin signaling and
amino acid transport through the CD98 light chain (CD98lc). In integrin signaling, suppression of the
M-CSF-RANKL-induced phosphorylation of ERK, Akt, JNK and p130Cas were observed at the triggering
phase in the CD98h-defect peritoneal macrophages. Moreover, we showed that the general control non-
derepressible (GCN) pathway, which was activated by amino acid starvation, was induced by the
CD98hc-defect peritoneal macrophages stimulated with RANKL. These results indicate that CD98 plays
two important roles in osteoclast formation through integrin signaling and amino acid transport.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osteoclasts are multinucleated giant cells responsible for bone
resorption and are derived from monocytes/macrophages. The
receptor activator of the NF-kb ligand (RANKL) plays a critical role
in osteoclastogenesis [1,2]. Previous research has shown that
when monocytes/macrophages were incubated with RANKL in the
presence of M-CSF, osteoclasts were induced [1,2].
Our previous study showed that anti-human CD98 heavy chain
monoclonal antibodies had the ability to induce multinucleated giant
cell formation of blood monocytes, and these giant cells had osteo-
clastic properties [3]. Thus, theCD98-mediated pathway is considered
to be intimately related to osteoclastogenesis. In addition, cross-talk
exists between these two pathways RANKL-mediated and CD98-
mediated pathways) [4]. CD98-mediated osteoclastogenesis is
blocked by the osteoclastogenesis inhibitory factor (OCIF), theB.V. This is an open access article usuppressive factor of RANKL-mediated osteoclastogenesis, and
RANKL-mediated osteoclastogenesis is suppressed by inhibitory
monoclonal antibodies directed against human CD98hc [4].
As CD98hc deﬁciency in mice produced an embryonic lethal
phenotype [5], we generated macrophage/neutrophil-speciﬁc
CD98hc-defect mice. CD98hc molecules were hardly found in the
peritoneal macrophages of these CD98hc conditional knock-out
mice (CD98hcﬂox/-LysM-cre mice) [6]. In our previous study, we
examined the role that CD98hc plays in the functions of macro-
phages using these tissue-speciﬁc knock-out mice [6]. Macrophage
functions, such as antigen-presenting and phagocytic activities, de-
creased in the CD98hc-defect peritoneal macrophages. Furthermore,
IL-4 induced giant cell formationwas inhibited in the CD98hc-defect
peritoneal macrophages. However, whether the defect of CD98hc
inﬂuences the activity of osteoclastogenesis remains to be clariﬁed.
To understand the CD98hc function in osteoclastogenesis, we
tried to clarify whether the CD98hc deﬁciency in the macrophages
affected osteoclast differentiation. In this study, osteoclast differ-
entiation was induced by two stimulations: RANKL stimulation andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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induced by RANKL signaling can be divided into three phases:
triggering, amplifying and targeting [7]. In this study, expression of
various factors was analyzed in each phase. Our results show that
multinucleated osteoclast formation is severely suppressed in the
peritoneal macrophages isolated from the CD98hc-defect mice.2. Materials and methods
2.1. Mice
CD98hcﬂox/ﬂox mice were crossed with LysM-cre knock-in mice
to delete the CD98hc gene from the macrophage as per methods
previously described [6]. All mice were housed at the National
Research Institute for Child Health and Development animal fa-
cility, and all experiments were approved by the Institutional
Animal Care and Use Committee.
2.2. Isolation of peritoneal macrophages
Peritoneal macrophages collected without any stimulation were
puriﬁed by incubating collected mouse peritoneal exudate cells with
FcR Blocking Reagent (Miltenyi Biotec) at 4 °C for 20 min [8]. The
cells were then further incubated with biotinylated anti-mouse F4/
80 mAb (eBioscience) at 4 °C for 20 min. After washing, the cells
were incubated with streptavidin-Microbeads (Milteyi Biotec) at 4 °C
for 20 min [7]. F4/80þ peritoneal macrophages (490%) were iso-
lated by positive selection using the MACS system (Milteyi Biotec).
2.3. Macrophage adhesion measurement
To complete attachment and spreading using the electric cell-
substrate impedance sensing (ECIS) device (Applied Biophysics),
two kinds of peritoneal macrophages were cultured in the pre-
sence of M-CSF (20 ng/ml) and RANKL (400 ng/ml) on ECIS elec-
trodes (8W10E). Adhesion and cell–cell contact were monitored by
measuring impedance for up to 48 h.
2.4. Osteoclast differentiation
Osteoclast differentiation was induced by two stimulations.
(1) Mouse peritoneal macrophages (1105/well) were cultured
in the presence of M-CSF (100 ng/ml) and RANKL (200–
400 ng/ml) for 9 days. Osteoclast formation was measured by
quantifying cells positively stained for TRAP, and light micro-
scopy was used to identify osteoclasts as TRAP-positive mul-
tinuclear (43 nuclei) cells.
(2) Mouse peritoneal macrophages (5103–4104/well) were co-
cultured with the mouse osteoblast cell line, UAMS-32, for
7 days. Peritoneal macrophages were cultured on 96 well plates
that were preseeded 24 h earlier with UAMS-32 (5103/well)
in the presence of 1,25(OH)2D3(108 M). After 3 days, the cul-
ture medium and added factors were replenished daily.
2.5. TRAP staining
Fixed cells were incubated for 30 min at 37 °C in acetate buffer
containing a-naphthol phasphate at pH 4 with 500 mM tartrate.
Next, fast violet was used to visualize the product.
2.6. Pit formation
To examine resorption pit formation, peritoneal macrophages
(4104/well) were cultured for 7 days on dentine slice in 96 wellplates preseeded 24 h earlier with UAMS-32 (5103/well) in the
presence of 1,25(OH)2D3(10–8 M). After 3 days, the culture med-
ium and added factors were replenished daily. To quantify re-
sorption lacunae, cells were removed from the bone slices using
mechanical agitation, and the bone slices were stained with 1%
toluidine blue for 20 min. Resorption pits were observed by
microscopy.
2.7. Actin ring
To observe the actin ring, cells were ﬁxed and then washed
with 0.2% Triton X-100 PBS and incubated with 0.2 U/ml of roda-
mine phalloidin (Molecular Probes) for 30 min and washed in PBS.
Rhodamine-phalloidin-stained actin rings were visualized using
ﬂuorescence microscopy.
2.8. Western blotting
Western blotting was carried out according to the method
previously described [6]. Blots were probed using the following
primary antibodies: β-actin (A1978, Sigma-Aldrich), CD98 (sc-
7094, Santa Cruz), NFATc1 (sc-7294, Santa Cruz), p130Cas
(MAB5730, R&D SYSTEMS), Phospho-p130Cas (#4015, Cell Signal),
Akt (#4691, Cell Signal), Phospho-Akt (#4668, Cell Signal), ERK
(#4695, Cell Signal), Phospho-ERK (#4370, Cell Signal), JNK
(#9258, Cell Signal), Phospho-JNK (#9258, Cell Signal), mTOR
(#2983, Cell Signal), Phospho-mTOR (#5536, Cell Signal), p70S6K
(#2708, Cell Signal), Phospho-p70S6K (#9234, Cell Signal), p38
(#9121, Cell Signal), Phospho-p38 (#4511, Cell Signal), S6 (#2217,
Cell Signal), Phospho-S6 (#4858, Cell Signal), Asparagine synthe-
tase (sc-135183, Santa Cruz), eIF2α (#5324, Cell Signal) and
Phospho- eIF2α (#3398, Cell Signal).
2.9. Statistical analysis
Data were analyzed using the Student’s two-tailed t-test.3. Results
3.1. CD98hc deletion in macrophages impairs spreading by stimu-
lation with M-CSF and RANKL
Since CD98hc is linked to/ plays a role in macrophage mobility,
we investigated whether the impedance and resistance of re-
sidential peritoneal macrophages are affected by defect of CD98hc.
First, the impedance and resistance of residential peritoneal
macrophages incubated with M-CSF and RANKL were monitored
quantitatively and in real-time on ECIS electrodes, in which im-
pedance and resistance represented attachment and spreading
respectively. Low attachment abilities between the macrophages
derived from CD98hcﬂox/ﬂoxLysM-cre (KO) mice and those from
CD98hcﬂox/ﬂox mice (Wild) were not detected for up to 6 h
(Fig. 1A). However, signiﬁcant differences in spreading were ob-
served from 20 h to 48 h (Fig. 1A).
In our previous study [6], when the macrophages were in-
cubated with MEM supplemented with FBS for 48 h, almost all
peritoneal macrophages derived from the CD98hcﬂox/ﬂoxLysM-cre
mice displayed a round-shaped morphology, while cells from
wild-type mice showed a spindle morphology. In this study, the
macrophages were stimulated with M-CSF and RANKL for 48 h,
and morphological observation was carried out. Interestingly, al-
most all peritoneal macrophages derived from CD98hc-defect
mice also displayed round-shaped morphologies (data not shown).
These data suggest that the defect of CD98hc suppressed the
spreading of macrophages stimulated by M-CSF and RANKL.
Fig. 1. Effect of peritoneal macrophage attachment and spreading by M-CSF and RANKL and effects of CD98hc-defect macrophages on in vitro osteoclastogenesis. (A) ECIS-
based attachment and spreading assay of macrophages from CD98hcﬂox/ﬂox LysM-cre (KO type mice) and CD98hcﬂox/ﬂox mice (wild-type mice). Peritoneal macrophages were
cultured in the presence of M-CSF (20 ng/ml) and RANKL (400 ng/ml) on an electric cell-substrate impedance-sensing electrode, and spreading was monitored by measuring
impedance for up to 48 h. Gray line: macrophages from KO-type mice. Black line: macrophages from wild-type mice. Impedance and resistance represent attachment and
spreading in macrophages. The experiment was performed in duplicate with 4 mice per group. Representative data are expressed as means þ SEM (**po0.01). (B) In the
RANKL system, mouse peritoneal macrophages were stimulated with M-CSF and RANKL for 9 days, followed by TRAP staining. (C) Quantitative analysis of TRAP-positive
multinucleated cells and number of nuclei per multinucleated cell in (B). The experiment was performed in duplicate with 5 mice per group. Representative data are
expressed as means þ SEM (*po0.05,**po0.01) .
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Fig. 2. CD98hc regulates osteoclast formation in the co-culture system. TRAP-stained osteoclasts in co-culture of UAMS-32 (osteoblasts cell line) and peritoneal macrophages.
Peritoneal macrophages (0.5104–4104/well) isolated from wild-type and knock-out type mice were co-cultured with UAMS-32 stimulated with VitD3 for 7 days. “W” or
“KO” means macrophages obtained from control or CD98hc knockout mice, respectively. (A) TRAP staining was carried out. (B) Higher magniﬁcation of wells of 4104
peritoneal macrophages. (C) TRAP-positive areas in wells of 4104 peritoneal macrophages were calculated by color extraction system of Hybrid Cell Count (KEYENCE). The
experiment was performed in duplicate with 6 mice per group. Representative data are expressed as means þ SEM (**p¼0.00003). (D) Resorption pit formation and actin ring.
(E) NFATc1 protein in wild-type and knock-out type peritoneal macrophages mixed with UAMS-32 were immunoblotted. Actin served as loading control. The experiment was
performed with 4 mice per group. Bellow, staining of NFATc1 was normalized to that actin. Data are representative of means þ SEM (**p¼0.0003).
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To determine the roles of CD98hc in osteoclast differentiation,
we ﬁrst investigated the osteoclastogenesis of peritonealmacrophages stimulated by RANKL. TRAP-positive osteoclasts
were generated from peritoneal macrophages derived from wild-
type mice in the presence of M-CSF and RANKL, but TRAP-positive
osteoclast formation was signiﬁcantly impaired in macrophages
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Furthermore, peritoneal macrophages were co-cultured for
7 days with the osteoblast cell line, UAMS-32. The number of os-
teoclasts was obviously lower in CD98hcﬂox/ﬂoxLysM-cre mice than
CD98hcﬂox/ﬂox mice (Fig. 2A–C). We found a marked difference in
actin ring formation and bone resorption between the osteoclasts
derived from CD98hcﬂox/ﬂox mice and CD98hcﬂox/ﬂoxLysM-cre mice
(Fig. 2D).
The essential role of transcription factor NFATc1 in osteoclast
differentiation is well established. We therefore examined the
expression of NFATc1 at day 7 of culture. Intriguingly, NFATc1 in-
duction was suppressed in the peritoneal macrophages of LysM-
cre-mediated CD98hc deletion (Fig. 2E).
3.3. CD98hc deletion in macrophages exacerbates signal transduc-
tion related to osteoclast formation
Peritoneal macrophages were cultured at various time points
(0–30 min) (triggering phase) after treatment with M-CSF and
RANKL. Cell lysates were prepared and probed by immunoblotting
with the antibodies listed in the Materials and Methods section. As
known well, CD98hc associates with integrin ß subunits, and
regulates integrin signaling which governs cell migration. Phos-
phorylation of p130cas is the initiating step that mediates in-
tegrin-dependent Rac activation. As shown in Fig. 3, the phos-
phorylation p130cas was impaired at the triggering phase in
CD98hcﬂox/ﬂoxLysM-cre macrophages. To explore the molecular
mechanism underlying the involvement of CD98hc in osteoclast
differentiation, we analyzed phosphorylation of downstream sig-
naling molecules of M-CSF and RANKL, such as Akt, ERK, JNK,
p70S6K, S6 and p38 at the triggering phase. The activation of Akt,
ERK and JNK were signiﬁcantly decreased in CD98hcﬂox/ﬂoxLysM-
cre peritoneal macrophages treated with M-CSF and RANKL
(Fig. 3). These results suggest that in the peritoneal macrophage
culture system, CD98hc molecules mediate osteoclast differentia-
tion in cooperation with M-CSF and RANKL.
3.4. CD98hc deletion causes amino acid deprivation in osteoclast
differentiation
The major amino acid sensing-signaling pathways in mamma-
lian cells are the mammalian target of rapamycin complex 1Fig. 3. Immunoblotting analysis of signal events in CD98hcﬂox/ﬂoxLysM-cre perito-
neal macrophages. Peritoneal macrophages were cultured at various time points
(0–30 min) (triggering phase) after treatment with M-CSF and RANKL. Cell lysates
were prepared and probed by immunoblotting with the antibodies listed in the
Materials and Methods section.(mTORC1) and GCN pathways [9]. The CD98 heterodimer is
formed by disulﬁde bonds between the CD98hc extracellular do-
main and one of several L-type amino acid transporters (LAT1/
Slc7a5, LAT2/Slc7a8, yþLAT1/Slc7a7, yþLAT2/Slc7a6, Asc-1/Slc7a10,
xCT/Slc7a11). CD98-mediated amino acid transport is related to
mTOR-p70S6K-S6 signaling [10]. To assess whether CD98hc/lc
support osteoclast differentiation through amino acid sensing, we
analyzed the phosphorylation of mTOR, p70S6K and S6 in perito-
neal macrophages stimulated by M-CSF and RANKL for 30 min (at
the triggering phase, Fig. 3) or 3 days (at the targeting phase (Fig. 4
A and B). The induction of phosophorylated p70S6K and S6 were
similar at the triggering and targeting phases between both groups
(Figs. 3 and 4A and B). Furthermore, no difference in mTOR and
p38 phosphorylation between both macrophages was observed
(Fig. 3). Asparagine synthetase (ASNS) encodes an enzyme in-
volved in asparagine biosynthesis [11], which is induced after
amino acid deprivation, low glucose and hypoxia [12], and the
ASNS gene is regulated by the GCN2-eIF2-ATF4 pathway [13]. We
investigated amino acid deprivation in the process of osteoclast
formation. Expression of ASNA at protein level (at the targeting
phase, Fig. 4A and B) and its mRNA (at the amplifying phase,
Fig. 4C) was enhanced in the CD98 knockout peritoneal macro-
phages compared to the control macrophages. Induction of phos-
ophorylated eIF2 increased in the CD98hcﬂox/ﬂoxLysM-cre perito-
neal macrophages that were treated with M-CSF and RANKL at the
targeting phase (Fig. 4A and B).
As described previously, when macrophages were co-cultured
with the osteoblast cell line for 7 days, NFATc1 induction was
suppressed in peritoneal macrophages with LysM-cre-mediated
CD98hc deletion (Fig. 2E). In addition, peritoneal macrophages
were cultured for 24 h (amplifying phase) after treatment with
M-CSF and RANKL. mRNA transcripts related to osteoclastogenesis
and fusion were analyzed with GeneChip analysis. However, no
difference in these mRNAs expression was found at the amplifying
phase between the CD98-defect macrophages and the wild-type
macrophages (Fig. 4C).
3.5. Trabecular bone was normal in CD98hcﬂox/ﬂoxLysM-cre mice
As the multinucleated osteoclast formation was severely im-
paired in the macrophages isolated from the CD98hc-defect mice,
we examined whether CD98hc-defect mice showed the osteope-
trosis phenotype. However, mCT analysis of CD98hcﬂox/ﬂoxLysM-cre
mice showed tibia of normal size and thickness compared with
CD98hcﬂox/ﬂox mice at 6 weeks of age (data, not shown).　Fur-
thermore, TRAP staining of mouse whole calvaria obtained from
wild-type and knock-out type mouse (Fig. 5). There was no dif-
ference in number of TRAP positive cells between both mice.4. Discussion
In this report, we demonstrated that CD98hc deﬁciency im-
paired the osteoclast formation induced by M-CSF-RANKL system
or co-culture system in vitro. When control peritoneal macro-
phages derived from wild-type mice were stimulated by RANKL,
TRAP-positive osteoclasts were generated. On the other hand,
multinucleated osteoclastogenesis was signiﬁcantly impaired in
RANKL-stimulated macrophages derived from CD98hcﬂox/ﬂoxLysM-
cre mice. Furthermore, when peritoneal macrophages were co-
cultured with the osteoblast cell line(UAMS-32), the number of
osteoclasts was lower in the macrophages derived from CD98hc-
defect mice than those derived from wild-type mice. Actin ring
formation and bone resorption activity were scarcely found in
CD98hc–defect macrophages.
Our previous study showed that CD98hc deﬁciency in mice
Fig. 4. Induction of GCN pathway in CD98hc ablation. (A) GCN and mTORC1 signaling in CD98hcﬂox/ﬂoxLysM-cre peritoneal macrophages. Peritoneal macrophages were
cultured for 3 days (targeting phase) after treatment with M-CSF and RANKL. Cell lysates were prepared and probed by immunoblotting with the antibodies listed in the
Materials and Methods section. “W” or “KO” means macrophages obtained from control or CD98hc knockout mice, respectively. (B) The experiment was performed with
6 mice per group. The staining density were normalized. Data are representative of meansþSEM (**po0.01). (C) Peritoneal macrophages were cultured for 24 h (amplifying
phase) after treatment with M-CSF and RANKL. mRNA transcripts were amalyzed with GeneChip analysis. Left panel: mRNA expression level at 24 h; right panel: the fold
increases in the mRNA expression level compared with that in unstimulated cells (control). ASNS: asparagine synthetase, GCN2: general control nonderepressible 2, eu-
karyotic translation initiation factor 2 alpha kinase 4, TRAP: Tartrate-resistant acid phosphatase, NFATc1: nuclear factor of activated T-cells, cytoplasmic, calcineurin-de-
pendent 1, RANK: Receptor activator of nuclear factor kappa-B, Ctsk: Cathepsin K, Mmp9: Matrix metallopeptidase 9, Itgb3: integrin beta 3, Calcr: calcitonin receptor, Tm7sf4
DC-STAMP: Dendritic Cells (DC)-Speciﬁc Transmembrane Protein, Acp5: Acid Phosphatase 5.
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Fig. 5. TRAP staining of mouse whole calvaria obtained from wild-type and knock-out type mouse at 6 weeks of age.
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physiological relevance of CD98 function, some researchers gen-
erated genetically manipulated mice that exhibited cell-speciﬁc
downregulation such as ES cells [14], MEF [15], T cells [16,17], B
cells [18], macrophages [5], intestinal epithelial cells [19] and
vascular smooth muscle [20]. Transmembrane and cytoplasmic
CD98hc are also found to mediate integrin signaling such as FAK
[14,21], PI3-kinase [14,21] and Erk [18,22]. On the other hand,
amino acid transport is dependent on the extracellular domain of
CD98hc, and surface expression of CD98lc is dependent on the
presence of CD98hc [23]. Six CD98lc are identiﬁed as system L
(LAT1/Slc7a5 and LAT2/Slc7a8), system yþL (yþLAT1/Slc7a7 and
yþLAT2/Slc7a6), system asc (Asc-1/Slc7a10) and Xc- (xCT/Slc7a11).
In our previous study [6], we examined the role that CD98hc
plays in the functions of macrophages using tissue-speciﬁc knock-
out mice. Macrophage functions, such as antigen-presenting and
phagocytic activities, decreased in the CD98hc-defect peritoneal
macrophages. Furthermore, when the peritoneal macrophages
were stimulated with IL-4 for 4 days, multinucleated giant-cell
formation was severely suppressed in the CD98hc-defect perito-
neal macrophages, thus showing that CD98hc plays an essential
role in macrophage fusion induced by IL4. This study shows that
RANKL-induced multinucleated giant-cell formation is also im-
paired in the CD98hc-defect peritoneal macrophages.
The suppression of the M-CSF-RANKL-induced phosphorylation
of ERK, Akt, JNK and p130Cas were observed in the CD98hcﬂox/
ﬂoxLysM-cre peritoneal macrophages. In contrast, p-p70S6K and
p-S6 expression levels in the peritoneal macrophages from
CD98hcﬂox/ﬂoxLysM-cre mice were not changed in macrophages
that were stimulated with RANKL and M-CSF at both the triggering
and targeting phases. Recently, the import of essential amino acids
in CD98hc/LAT1 bidirectional transport was found to regulate a
rate-limiting step that activates mTOR [10]. The uptake of essential
amino acids also regulates T-cell differentiation and muscle mass
[24,25]. Rapamycin-sensitive mTOR complex 1 in mammalian cells
is important for phosphorylation and activation of p70S6K [10].
Intriguingly, our results did not show the inhibition of phosphor-
ylation of mTOR, p70S6K and p-S6 in the CD98hcﬂox/ﬂoxLysM-cre
peritoneal macrophages. LAT-1 mRNAwas not found in monocytes
stimulated with M-CSF and RANKL [4]. It is possible we did not
observe the mTOR signal disorder in CD98hcﬂox/ﬂoxLysM-cre peri-
toneal macrophages due to the tissue distribution of CD98lc. Taken
together, the amino acid transports of CD98lc were also impaired
by the CD98hc defect, and resulted in amino acid starvation such
as GCN pathway activation.CD98hc plays two important roles in osteoclastogenesis
through integrin signaling and amino acid transport in mice. We
have demonstrated that CD98 has a signiﬁcant function in osteo-
clastogenesis in mice. However, CD98hcﬂox/ﬂoxLysM-cre mice ex-
hibited tibia of normal size and thickness compared with
CD98hcﬂox/ﬂox mice at 6 weeks of age. The role of CD98hc in in vivo
osteoclast formation still needs to be clariﬁed, and we aim to
further investigate this role using cathepsin K-cre mice in the near
future.Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.bbrep.2015.11.023.References
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